Latest On Arrowhead Pharmaceuticals, Inc (ARWR):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-27 12:46 EST | News | Stocks To Watch: Spotlight On AI Buzz, May Jobs Report And Disney's Mermaids | N/A |  |
| 2023-05-23 23:45 EST | News | Arrowhead says anti-lipid agent caused up to 48% decline in bad cholesterol | N/A | |
| 2023-05-19 21:32 EST | News | Arrowhead Pharmaceuticals Remains A Buy For Pipeline Potential | N/A | |
| 2023-05-03 07:56 EST | News | Arrowhead Pharmaceuticals, Inc. (ARWR) Q2 2023 Earnings Call Transcript | N/A | |
| 2023-05-02 19:57 EST | News | Arrowhead Pharmaceuticals GAAP EPS of $0.45 beats by $1.06, revenue of $146.26M beats by $100.78M | N/A | |
| 2023-04-25 15:00 EST | News | Arrowhead Pharma surges 16% on positive data from early-stage trial of inflammatory pulmonary diseases therapy | N/A | |
| 2023-04-25 15:00 EST | News | Arrowhead rises 17% after early data for asthma candidate | N/A | |
| 2023-04-12 14:33 EST | News | Arrowhead adds 11% as SVB upgrades on compelling risk-reward setup | N/A | |
| 2023-04-11 10:13 EST | News | Arrowhead: A Compelling Investment In RNAi Therapeutics With Significant Upside Potential | N/A | |
| 2023-04-04 10:53 EST | News | Arrowhead to get $40M milestone as Takeda starts fazirsiran dosing in liver disease trial | N/A | |
| 2023-04-03 17:49 EST | News | Arrowhead stock pops after $30M milestone from GSK under liver drug pact | N/A | |
| 2023-03-20 09:55 EST | News | Arrowhead wins FDA Fast Track status for lipid lowering agent | N/A | |
| 2023-02-28 16:56 EST | News | Arrowhead's RNAi therapy for complement disorders shows promise in interim trial data | N/A | |
| 2023-02-24 01:28 EST | News | Arrowhead Pharmaceuticals Requires Caution | N/A | |
| 2023-02-15 21:47 EST | News | J&J returns rights to NASH RNAi candidate to Arrowhead Pharmaceuticals | N/A | |
| 2023-02-07 03:45 EST | News | Arrowhead Pharmaceuticals EPS of -$0.39, revenue of $62.55M | N/A | |
| 2023-02-07 03:44 EST | News | Arrowhead Pharmaceuticals' fiscal 2023 Q1 revenue surge helped by milestone payments | N/A | |
| 2023-02-07 03:44 EST | News | Arrowhead Pharmaceuticals, Inc. (ARWR) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-02-06 15:01 EST | News | Arrowhead drops as Cantor flags risks to Johnson & Johnson licensing deal | N/A | |
| 2023-02-03 18:33 EST | News | Arrowhead Pharmaceuticals Q1 2023 Earnings Preview | N/A | |
| 2023-01-09 13:36 EST | News | Arrowhead stock dips ~15% amid phase 2 data for liver disease drug fazirsiran | N/A | |
| 2023-01-07 11:45 EST | News | Stocks To Watch: Citigroup, Wells Fargo And JPMorgan Lead Off Earnings Season | N/A | |
| 2022-12-21 18:18 EST | News | Arrowhead Pharmaceuticals: Good Work In Progress | N/A | |
| 2022-12-21 01:48 EST | News | Arrowhead receives $25M milestone payment from Amgen for heart disease treatment | N/A | |
| 2022-11-29 02:06 EST | News | Arrowhead Pharmaceuticals GAAP EPS of -$1.67 misses by $0.70, revenue of $243.23M misses by $50.38M | N/A | |
| 2022-11-29 02:06 EST | News | Arrowhead Pharmaceuticals, Inc. (ARWR) Q4 2022 Earnings Call Transcript | N/A | |
| 2022-11-28 08:03 EST | News | Arrowhead Pharmaceuticals Q4 2022 Earnings Preview | N/A | |
| 2022-11-12 01:20 EST | News | Arrowhead Pharmaceuticals (ARWR) Presents at AHA Scientific Sessions 2022 | N/A | |
| 2022-11-09 20:42 EST | News | Arrowhead sells royalty interest in olpasiran to Royalty Pharma for $250M | N/A | |
| 2022-11-09 02:35 EST | News | Arrowhead Pharmaceuticals: Olpasiran's Impressive Phase 2 Data | N/A | |
| 2022-09-13 06:59 EST | News | Arrowhead Pharmaceuticals: Emerging From The 'Data Desert' With A Flood Of Opportunities | N/A | |
| 2022-08-24 00:48 EST | News | Johnson & Johnson And Arrowhead Pharmaceuticals Could Have Big News Coming | N/A | |
| 2022-08-17 14:32 EST | News | Arrowhead seeks New Zealand regulator nod to start trial of ARO-MMP7 for lung disease | N/A | |
| 2022-08-04 23:37 EST | News | Arrowhead Pharmaceuticals GAAP EPS of -$0.68 misses by $0.21, revenue of $32.41M misses by $20.2M | N/A | |
| 2022-08-04 23:36 EST | News | Arrowhead Pharmaceuticals, Inc. (ARWR) CEO Christopher Anzalone on Q3 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-04 08:03 EST | News | Arrowhead Pharmaceuticals Q3 2022 Earnings Preview | N/A | |
| 2022-07-28 20:46 EST | News | Arrowhead Pharmaceuticals: An RNAi Name To Know | N/A | |
| 2022-07-20 18:52 EST | News | Arrowhead Pharmaceuticals names internal officer as new COO | N/A | |
| 2022-07-06 02:51 EST | News | Arrowhead begins dosing in early-stage studies of 2 potential lung disease drugs | N/A | |
| 2022-06-28 19:07 EST | News | Arrowhead Pharma: We Can Afford To Wait For More Proof | N/A | |
| 2022-06-10 12:27 EST | News | Arrowhead Pharmaceuticals (ARWR) Investor Presentation - Slideshow | N/A | |
| 2022-05-11 19:32 EST | News | Arrowhead Pharma down 12% despite quarterly beats, swing to net gain | N/A | |
| 2022-05-11 00:19 EST | News | Arrowhead Pharmaceuticals GAAP EPS of $0.41 beats by $0.12, revenue of $151.8M beats by $29.65M | N/A | |
| 2022-05-11 00:19 EST | News | Arrowhead Pharmaceuticals, Inc. (ARWR) CEO Christopher Anzalone on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-10 02:23 EST | News | Arrowhead Pharmaceuticals FQ2 2022 Earnings Preview | N/A | |
| 2022-04-29 20:59 EST | News | Oligonucleotide-Based Therapeutics Conference | N/A | |
| 2022-04-26 09:00 EST | News | Arrowhead begins dosing in phase 2 trial of ARO-ANG3 to treat cholesterol disorder | N/A | |
| 2022-04-14 19:36 EST | News | Arrowhead Pharma: Know Pros'Â Calcs For Coming Stock Prices | N/A | |
| 2022-03-25 14:23 EST | News | Arrowhead Pharmaceuticals asks regulators to begin early-stage asthma trial | N/A | |
| 2022-02-24 08:57 EST | News | Arrowhead finishes enrollment in phase 2b trial of ARO-ANG3 for mixed dyslipidemia | N/A | |
About Arrowhead Pharmaceuticals, Inc (ARWR):
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in Phase I/II clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in Phase I/II clinical trial to reduce production of angiopoietin-like protein 3; ARO-HSD, which is in Phase I/II clinical trial for treating liver diseases; ARO-ENaC, which is in Phase I/II clinical trial to reduce production of the epithelial sodium channel alpha subunit in the airways of the lung; ARO-Lung2 for the treatment of chronic obstructive pulmonary disorder; ARO-COV for the treatment of COVID-19 and other pulmonary-borne pathogens; and ARO-HIF2, which is in phase Ib for the treatment of clear cell renal cell carcinoma. It is also involved in the development of JNJ-3989, a subcutaneously administered RNAi therapeutic candidate to treat chronic hepatitis B virus infection; Olpasiran to reduce production of apolipoprotein A; and ARO-AMG1 for treating genetically validated cardiovascular target. Arrowhead Pharmaceuticals, Inc. has license and research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop ARO-JNJ1, ARO-JNJ2, and ARO-JNJ3 RNAi therapeutics for liver-expressed targets; and license and research collaboration agreement with Takeda Pharmaceuticals U.S.A., Inc. to develop RNAi therapeutic candidate. The company was formerly known as Arrowhead Research Corporation and changed its name to Arrowhead Pharmaceuticals, Inc. in April 2016. Arrowhead Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Pasadena, California.
General
- Name Arrowhead Pharmaceuticals, Inc
- Symbol ARWR
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 232
- Last Split Factor1:10
- Last Split Date2011-11-17
- Fiscal Year EndSeptember
- IPO Date1993-06-16
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://arrowheadpharma.com
View More
Valuation
- Trailing PE 478.56
- Forward PE 111.11
- Price/Sales (Trailing 12 Mt.) 92.84
- Price/Book (Most Recent Quarter) 16.57
- Enterprise Value Revenue 90.78
- Enterprise Value EBITDA 739.74
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.55
- Next Year EPS Estimate -$0.64
- Next Quarter EPS Estimate -$0.27
- Profit Margin -129%
- Operating Margin -141%
- Return on Assets -13%
- Return on Equity -22%
- Revenue 79.84 million
- Earnings Per Share $0.09
- Revenue Per Share $0.78
- Gross Profit 87.99 million
- Quarterly Earnings Growth -27.7%
View More
Highlights
- Market Capitalization 7.04 billion
- EBITDA 5.86 million
- PE Ratio -9.44
- PEG Ratio -1.32
- Analyst Target Price $92.42
- Book Value Per Share $4.40
View More
Share Statistics
- Shares Outstanding 103.79 million
- Shares Float 100.46 million
- % Held by Insiders 260%
- % Held by Institutions 67.06%
- Shares Short 5.14 million
- Shares Short Prior Month 5.02 million
- Short Ratio 6.32
- Short % of Float 6%
- Short % of Shares Outstanding 5%
View More
Technicals
- Beta 1.39
- 52 Week High $92.6
- 52 Week Low $24.5
- 50 Day Moving Average 79.93
- 200 Day Moving Average 66.13
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Arrowhead Pharmaceuticals, Inc (ARWR) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Arrowhead Pharmaceuticals, Inc (ARWR) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-04 | $21.3 million | -$0.20 | -$0.24 | 17.59% |
| 2020-09-30 | 2020-11-23 | $7.63 million | -$0.48 | -$0.21 | -134.03% |
| 2020-06-30 | 2020-08-05 | $N/A | -$0.13 | -$0.21 | 36.59% |
| 2020-03-31 | 2020-05-07 | $N/A | -$0.20 | -$0.11 | -85.19% |
| 2019-12-31 | 2020-02-05 | $29.45 million | -$0.03 | -$0.07 | 55.02% |
| 2019-09-30 | 2019-11-25 | $43.29 million | $0.11 | $0.17 | -34.01% |
| 2019-06-30 | 2019-08-05 | $42.7 million | $0.21 | $0.12 | 75% |
| 2019-03-31 | 2019-05-08 | $48.15 million | $0.24 | $0.20 | 21.21% |
| 2018-12-31 | 2019-02-07 | $34.66 million | $0.13 | $0.69 | -81.27% |
| 2018-09-30 | 2018-12-11 | $11.26 million | -$0.12 | -$0.17 | 30.76% |
| 2018-06-30 | 2018-08-07 | $727375 | -$0.18 | -$0.19 | 4.41% |
| 2018-03-31 | 2018-05-08 | $650125 | -$0.18 | -$0.19 | 2.7% |
| 2017-12-31 | 2018-02-09 | $3.51 million | -$0.18 | -$0.16 | -10.77% |
| 2017-09-30 | 2017-12-12 | $8.71 million | -$0.14 | -$0.12 | -16.67% |
| 2017-06-30 | 2017-08-03 | $9.34 million | -$0.07 | -$0.12 | 43.55% |
| 2017-03-31 | 2017-05-03 | $8.99 million | -$0.08 | -$0.18 | 54.55% |
| 2016-12-31 | 2017-02-06 | $4.37 million | -$0.17 | -$0.21 | 19.05% |
| 2016-09-30 | 2016-12-14 | $31000 | -$0.31 | -$0.31 | 2.24% |
| 2016-06-30 | 2016-08-09 | $39000 | -$0.32 | -$0.36 | 11.72% |
| 2016-03-31 | 2016-05-10 | $44000 | -$0.35 | -$0.36 | 3.45% |
| 2015-12-31 | 2016-02-09 | $44000 | -$0.32 | -$0.38 | 15.79% |
| 2015-09-30 | 2015-12-14 | $44000 | -$0.41 | -$0.39 | -5.13% |
| 2015-06-30 | 2015-08-04 | $123000 | -$0.27 | -$0.38 | 28.95% |
| 2015-03-31 | 2015-05-11 | $44000 | -$0.51 | -$0.34 | -50% |
| 2014-12-31 | 2015-02-09 | $171000 | -$0.41 | -$0.34 | -20.59% |
| 2014-09-30 | 2014-11-25 | $44000 | -$0.33 | -$0.24 | -37.5% |
| 2014-06-30 | 2014-08-12 | $43000 | -$0.22 | -$0.22 | 0% |
| 2014-03-31 | 2014-05-06 | $44000 | -$0.31 | -$0.20 | -55% |
| 2013-12-31 | 2014-02-04 | $44000 | -$0.28 | -$0.20 | -40% |
| 2013-09-30 | 2013-12-18 | $43000 | -$0.38 | -$0.18 | -111.11% |
| 2013-06-30 | 2013-08-08 | $44000 | -$0.23 | ||
| 2013-03-31 | 2013-05-10 | $44000 | -$0.41 | ||
| 2012-12-31 | 2013-02-14 | $159000 | -$0.33 | ||
| 2012-09-30 | 2012-12-21 | $44000 | -$0.48 | ||
| 2012-06-30 | 2012-08-13 | $48000 | -$0.71 | ||
| 2012-03-31 | 2012-05-08 | $31000 | -$0.50 | ||
| 2011-12-31 | 2012-02-10 | $24000 | -$0.25 | ||
| 2011-09-30 | 2011-12-20 | $296000 | -$0.35 | ||
| 2011-06-30 | 2011-08-09 | $N/A | -$0.25 | ||
| 2011-03-31 | 2011-05-13 | $-296000 | $0.37 | ||
| 2010-12-31 | 2011-02-11 | $296000 | -$0.20 | ||
| 2010-09-30 | 2010-12-23 | $620000 | -$0.31 | ||
| 2010-06-30 | 2010-08-12 | $N/A | -$0.10 | -$0.45 | 77.78% |
| 2010-03-31 | 2010-05-13 | $N/A | -$0.30 | -$0.41 | 26.83% |
| 2009-12-31 | 2010-02-11 | $N/A | -$0.30 | -$0.55 | 45.45% |
| 2009-09-30 | 2009-12-23 | $187000 | -$0.77 | ||
| 2009-06-30 | 2009-08-11 | $2.63 million | -$0.58 | ||
| 2009-03-31 | 2009-05-15 | $235000 | -$1.23 | ||
| 2008-12-31 | 2009-02-10 | $702000 | -$1.87 | ||
| 2008-09-30 | 2008-12-16 | $1.07 million | -$2.14 | ||
| 2008-06-30 | 2008-09-03 | $235000 | -$1.93 | ||
| 2008-03-31 | 2008-05-28 | $725000 | -$1.47 | ||
| 2007-12-31 | 2008-02-11 | $403000 | -$2.11 | ||
| 2007-06-30 | 2007-08-29 | $623000 | -$3.43 | ||
| 2006-12-31 | 2007-02-28 | $11000 | -$1.08 | ||
| 2006-09-30 | 2006-11-29 | $39000 | -$2.58 | ||
| 2006-06-30 | 2006-08-30 | $246000 | -$1.18 | ||
| 2006-03-31 | 2006-05-31 | $57000 | -$0.97 | ||
| 2005-12-31 | 2006-03-01 | $253000 | -$1.12 | ||
| 2005-09-30 | 2005-11-30 | $211000 | -$0.51 | ||
| 2005-06-30 | 2005-06-30 | $173000 | -$1.62 | ||
| 2005-03-31 | 2005-03-31 | $78000 | $0.27 | ||
| 2004-12-31 | 2004-12-31 | $129000 | -$1.12 | ||
| 2004-09-30 | 2004-09-30 | $159000 | -$1.30 | ||
| 2004-06-30 | 2004-06-30 | $37000 | -$0.47 | ||
| 2004-03-31 | 2004-03-31 | $N/A | -$0.20 | ||
| 2003-12-31 | 2003-12-31 | $N/A | -$26.00 | ||
| 2003-09-30 | 2003-09-30 | $N/A | $44.28 | ||
| 2003-06-30 | 2003-06-30 | $N/A | -$6.59 | ||
| 2003-03-31 | 2003-03-31 | $N/A | -$12.91 | ||
| 2002-12-31 | 2002-12-31 | $N/A | -$5.56 | ||
| 2002-06-30 | 2002-06-30 | $-1000 | -$10.85 | ||
| 2002-03-31 | 2002-03-31 | $1000 | -$1.25 | ||
| 2001-12-31 | 2001-12-31 | $1000 | -$7.79 | ||
| 2001-06-30 | 2001-06-30 | $3000 | -$4.02 | ||
| 2001-03-31 | 2001-03-31 | $-5000 | -$6.43 | ||
| 2000-12-31 | 2000-12-31 | $5000 | -$5.16 | ||
| 2000-09-30 | 2000-09-30 | $9000 | $4.51 | ||
| 2000-06-30 | 2000-06-30 | $4000 | -$7.39 | ||
| 2000-03-31 | 2000-03-31 | $7000 | -$6.96 | ||
| 1999-12-31 | 1999-12-31 | -$8.00 | |||
| 1999-06-30 | 1999-06-30 | -$32.59 | |||
| 1999-03-31 | 1999-03-31 | -$3.16 |
Arrowhead Pharmaceuticals, Inc (ARWR) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Arrowhead Pharmaceuticals, Inc (ARWR) Chart:
Arrowhead Pharmaceuticals, Inc (ARWR) News:
Below you will find a list of latest news for Arrowhead Pharmaceuticals, Inc (ARWR) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Arrowhead Pharmaceuticals, Inc (ARWR) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 15 | 0 | CALL | 0 | 0 | 132.21 | TRUE | 0 | 0 |
| 2024-05-17 | 17.5 | 0 | CALL | 0 | 0 | 138.62 | TRUE | 0 | 0 |
| 2024-05-17 | 20 | 0 | CALL | 0 | 5 | 81.58 | TRUE | 0 | 0 |
| 2024-05-17 | 22.5 | 1.73 | CALL | 1 | 7 | 84.53 | TRUE | -0.3 | -0.15 |
| 2024-05-17 | 25 | 0.85 | CALL | 42 | 291 | 73.81 | FALSE | -0.15 | -0.15 |
| 2024-05-17 | 30 | 0.25 | CALL | 16 | 652 | 77.18 | FALSE | -0.15 | -0.38 |
| 2024-05-17 | 35 | 0.15 | CALL | 0 | 409 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 40 | 0.1 | CALL | 10 | 17 | 107.97 | FALSE | -0.3 | -0.75 |
| 2024-05-17 | 15 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 17.5 | 0.3 | PUT | 15 | 7 | 83.58 | FALSE | 0.3 | 0 |
| 2024-05-17 | 20 | 0.7 | PUT | 21 | 37 | 73.36 | FALSE | -0.1 | -0.13 |
| 2024-05-17 | 22.5 | 1.9 | PUT | 1 | 58 | 72.21 | FALSE | 1.9 | 0 |
| 2024-05-17 | 25 | 2.35 | PUT | 0 | 397 | 76.95 | TRUE | 0 | 0 |
| 2024-05-17 | 30 | 6.2 | PUT | 0 | 605 | 112.01 | TRUE | 0 | 0 |
| 2024-05-17 | 35 | 10.9 | PUT | 0 | 16 | 165.47 | TRUE | 0 | 0 |
| 2024-05-17 | 40 | 0 | PUT | 0 | 0 | 148.34 | TRUE | 0 | 0 |
| 2024-06-21 | 12.5 | 16.25 | CALL | 0 | 9 | 148.41 | TRUE | 0 | 0 |
| 2024-06-21 | 15 | 24.3 | CALL | 0 | 1 | 122.31 | TRUE | 0 | 0 |
| 2024-06-21 | 17.5 | 14.5 | CALL | 0 | 1 | 103.41 | TRUE | 0 | 0 |
| 2024-06-21 | 20 | 3.94 | CALL | 90 | 19 | 64.91 | TRUE | 3.94 | 0 |
| 2024-06-21 | 22.5 | 5.68 | CALL | 0 | 61 | 73.14 | TRUE | 0 | 0 |
| 2024-06-21 | 25 | 1.9 | CALL | 6 | 565 | 72.88 | FALSE | -0.35 | -0.16 |
| 2024-06-21 | 30 | 0.75 | CALL | 16 | 1103 | 71.85 | FALSE | -0.32 | -0.3 |
| 2024-06-21 | 35 | 0.4 | CALL | 15 | 596 | 78.36 | FALSE | -0.1 | -0.2 |
| 2024-06-21 | 40 | 0.35 | CALL | 0 | 396 | 88.47 | FALSE | 0 | 0 |
| 2024-06-21 | 45 | 0.15 | CALL | 0 | 190 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 50 | 1.05 | CALL | 0 | 100 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 55 | 0.17 | CALL | 0 | 161 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 12.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 15 | 0 | PUT | 0 | 0 | 101.88 | FALSE | 0 | 0 |
| 2024-06-21 | 17.5 | 0.85 | PUT | 0 | 7 | 88.66 | FALSE | 0 | 0 |
| 2024-06-21 | 20 | 0.7 | PUT | 0 | 144 | 74.51 | FALSE | 0 | 0 |
| 2024-06-21 | 22.5 | 2.65 | PUT | 2 | 830 | 75.33 | FALSE | 0.15 | 0.06 |
| 2024-06-21 | 25 | 3.4 | PUT | 0 | 287 | 71.97 | TRUE | 0 | 0 |
| 2024-06-21 | 30 | 8.4 | PUT | 4 | 1461 | 87.87 | TRUE | 0.9 | 0.12 |
| 2024-06-21 | 35 | 12.6 | PUT | 1 | 483 | 78.74 | TRUE | -0.51 | -0.04 |
| 2024-06-21 | 40 | 6.7 | PUT | 0 | 38 | 109.52 | TRUE | 0 | 0 |
| 2024-06-21 | 45 | 14.2 | PUT | 0 | 0 | 102.61 | TRUE | 0 | 0 |
| 2024-06-21 | 50 | 0 | PUT | 0 | 0 | 114.94 | TRUE | 0 | 0 |
| 2024-06-21 | 55 | 0 | PUT | 0 | 0 | 125.96 | TRUE | 0 | 0 |
| 2024-09-20 | 15 | 0 | CALL | 0 | 0 | 99.02 | TRUE | 0 | 0 |
| 2024-09-20 | 17.5 | 0 | CALL | 0 | 0 | 97.72 | TRUE | 0 | 0 |
| 2024-09-20 | 20 | 7.99 | CALL | 0 | 21 | 82.62 | TRUE | 0 | 0 |
| 2024-09-20 | 22.5 | 5.7 | CALL | 0 | 24 | 82.9 | TRUE | 0 | 0 |
| 2024-09-20 | 25 | 4 | CALL | 119 | 160 | 80.64 | FALSE | -0.12 | -0.03 |
| 2024-09-20 | 30 | 2.37 | CALL | 3 | 748 | 81.3 | FALSE | -0.24 | -0.09 |
| 2024-09-20 | 35 | 1.6 | CALL | 27 | 5565 | 77.75 | FALSE | -0.1 | -0.06 |
| 2024-09-20 | 40 | 1 | CALL | 56 | 312 | 76.75 | FALSE | -0.02 | -0.02 |
| 2024-09-20 | 45 | 0.95 | CALL | 0 | 312 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 50 | 0.63 | CALL | 0 | 184 | 85.43 | FALSE | 0 | 0 |
| 2024-09-20 | 15 | 0 | PUT | 0 | 0 | 91.6 | FALSE | 0 | 0 |
| 2024-09-20 | 17.5 | 1.8 | PUT | 0 | 22 | 91.13 | FALSE | 0 | 0 |
| 2024-09-20 | 20 | 3.2 | PUT | 7 | 471 | 84.24 | FALSE | 0.2 | 0.07 |
| 2024-09-20 | 22.5 | 2.5 | PUT | 0 | 35 | 86 | FALSE | 0 | 0 |
| 2024-09-20 | 25 | 4.9 | PUT | 0 | 225 | 94.57 | TRUE | 0 | 0 |
| 2024-09-20 | 30 | 9.3 | PUT | 8 | 238 | 77.41 | TRUE | 9.3 | 0 |
| 2024-09-20 | 35 | 11.3 | PUT | 0 | 178 | 77.16 | TRUE | 0 | 0 |
| 2024-09-20 | 40 | 17.82 | PUT | 100 | 1 | 76.01 | TRUE | 17.82 | 0 |
| 2024-09-20 | 45 | 0 | PUT | 0 | 0 | 84.5 | TRUE | 0 | 0 |
| 2024-09-20 | 50 | 0 | PUT | 0 | 0 | 83.26 | TRUE | 0 | 0 |
| 2024-12-20 | 16 | 0 | CALL | 0 | 0 | 84.25 | TRUE | 0 | 0 |
| 2024-12-20 | 17 | 0 | CALL | 0 | 0 | 85.09 | TRUE | 0 | 0 |
| 2024-12-20 | 18 | 0 | CALL | 0 | 0 | 79.97 | TRUE | 0 | 0 |
| 2024-12-20 | 19 | 0 | CALL | 0 | 0 | 81.56 | TRUE | 0 | 0 |
| 2024-12-20 | 20 | 0 | CALL | 0 | 0 | 84.91 | TRUE | 0 | 0 |
| 2024-12-20 | 21 | 0 | CALL | 0 | 0 | 79.89 | TRUE | 0 | 0 |
| 2024-12-20 | 22 | 6.1 | CALL | 11 | 0 | 76.31 | TRUE | 6.1 | 0 |
| 2024-12-20 | 23 | 0 | CALL | 0 | 0 | 79.02 | FALSE | 0 | 0 |
| 2024-12-20 | 24 | 0 | CALL | 0 | 0 | 74.22 | FALSE | 0 | 0 |
| 2024-12-20 | 25 | 4.72 | CALL | 4 | 0 | 72.3 | FALSE | 4.72 | 0 |
| 2024-12-20 | 26 | 0 | CALL | 0 | 0 | 76.38 | FALSE | 0 | 0 |
| 2024-12-20 | 27 | 4.35 | CALL | 4 | 0 | 75.63 | FALSE | 4.35 | 0 |
| 2024-12-20 | 28 | 0 | CALL | 0 | 0 | 77.32 | FALSE | 0 | 0 |
| 2024-12-20 | 29 | 0 | CALL | 0 | 0 | 77.07 | FALSE | 0 | 0 |
| 2024-12-20 | 30 | 3.4 | CALL | 20 | 0 | 73.19 | FALSE | 3.4 | 0 |
| 2024-12-20 | 31 | 0 | CALL | 0 | 0 | 73.15 | FALSE | 0 | 0 |
| 2024-12-20 | 32 | 0 | CALL | 0 | 0 | 65.17 | FALSE | 0 | 0 |
| 2024-12-20 | 16 | 0 | PUT | 0 | 0 | 73.5 | FALSE | 0 | 0 |
| 2024-12-20 | 17 | 0 | PUT | 0 | 0 | 69.56 | FALSE | 0 | 0 |
| 2024-12-20 | 18 | 0 | PUT | 0 | 0 | 78.33 | FALSE | 0 | 0 |
| 2024-12-20 | 19 | 0 | PUT | 0 | 0 | 69.67 | FALSE | 0 | 0 |
| 2024-12-20 | 20 | 0 | PUT | 0 | 0 | 72 | FALSE | 0 | 0 |
| 2024-12-20 | 21 | 0 | PUT | 0 | 0 | 73.98 | FALSE | 0 | 0 |
| 2024-12-20 | 22 | 0 | PUT | 0 | 0 | 77.94 | FALSE | 0 | 0 |
| 2024-12-20 | 23 | 0 | PUT | 0 | 0 | 83.1 | TRUE | 0 | 0 |
| 2024-12-20 | 24 | 0 | PUT | 0 | 0 | 75.01 | TRUE | 0 | 0 |
| 2024-12-20 | 25 | 0 | PUT | 0 | 0 | 80.7 | TRUE | 0 | 0 |
| 2024-12-20 | 26 | 0 | PUT | 0 | 0 | 70.17 | TRUE | 0 | 0 |
| 2024-12-20 | 27 | 0 | PUT | 0 | 0 | 65.58 | TRUE | 0 | 0 |
| 2024-12-20 | 28 | 8.6 | PUT | 2 | 0 | 75.04 | TRUE | 8.6 | 0 |
| 2024-12-20 | 29 | 0 | PUT | 0 | 0 | 78.09 | TRUE | 0 | 0 |
| 2024-12-20 | 30 | 0 | PUT | 0 | 0 | 72.6 | TRUE | 0 | 0 |
| 2024-12-20 | 31 | 0 | PUT | 0 | 0 | 66.68 | TRUE | 0 | 0 |
| 2024-12-20 | 32 | 0 | PUT | 0 | 0 | 76.88 | TRUE | 0 | 0 |
Latest ARWR Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 4 | $28.31 |
| Jun 13, 2022 7:59 PM EST | 100 | $28.31 |
| Jun 13, 2022 7:59 PM EST | 100 | $28.29 |
| Jun 13, 2022 7:59 PM EST | 100 | $28.29 |
| Jun 13, 2022 7:59 PM EST | 100 | $28.29 |
Arrowhead Pharmaceuticals, Inc (ARWR) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120039148/0001209191-20-039148-index.htm |
| 2019-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/879407/000009375119000156/0000093751-19-000156-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/879407/000009375120000450/0000093751-20-000450-index.htm |
| 2019-02-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/879407/000021545719006706/0000215457-19-006706-index.htm |
| 2019-06-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/879407/000021545719008046/0000215457-19-008046-index.htm |
| 2019-01-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/879407/000072888919000064/0000728889-19-000064-index.htm |
| 2020-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/879407/000083423720001655/0000834237-20-001655-index.htm |
| 2019-02-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/879407/000095012319000828/0000950123-19-000828-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/879407/000110465920017461/0001104659-20-017461-index.htm |
| 2019-10-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/879407/000114420419047872/0001144204-19-047872-index.htm |
| 2018-10-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/879407/000119312518292844/0001193125-18-292844-index.htm |
| 2018-11-29 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/879407/000119312518338204/0001193125-18-338204-index.htm |
| 2019-01-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/879407/000119312519007504/0001193125-19-007504-index.htm |
| 2019-01-25 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/879407/000119312519017078/0001193125-19-017078-index.htm |
| 2019-01-25 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/879407/000119312519017089/0001193125-19-017089-index.htm |
| 2019-01-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/879407/000119312519021050/0001193125-19-021050-index.htm |
| 2019-03-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/879407/000119312519076873/0001193125-19-076873-index.htm |
| 2019-03-29 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/879407/000119312519092836/0001193125-19-092836-index.htm |
| 2019-12-02 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/879407/000119312519304271/0001193125-19-304271-index.htm |
| 2019-12-02 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/879407/000119312519304378/0001193125-19-304378-index.htm |
| 2019-12-05 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/879407/000119312519306528/0001193125-19-306528-index.htm |
| 2019-12-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/879407/000119312519308250/0001193125-19-308250-index.htm |
| 2019-12-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/879407/000119312519316457/0001193125-19-316457-index.htm |
| 2020-01-14 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/879407/000119312520007280/0001193125-20-007280-index.htm |
| 2020-01-28 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/879407/000119312520017001/0001193125-20-017001-index.htm |
| 2020-05-22 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/879407/000119312520150108/0001193125-20-150108-index.htm |
| 2020-08-05 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/879407/000119312520210786/0001193125-20-210786-index.htm |
| 2018-03-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919118021843/0001209191-18-021843-index.htm |
| 2018-04-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919118026146/0001209191-18-026146-index.htm |
| 2018-06-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919118034785/0001209191-18-034785-index.htm |
| 2018-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919118038884/0001209191-18-038884-index.htm |
| 2018-09-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919118049552/0001209191-18-049552-index.htm |
| 2018-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919118050356/0001209191-18-050356-index.htm |
| 2018-10-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919118055999/0001209191-18-055999-index.htm |
| 2018-10-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919118056001/0001209191-18-056001-index.htm |
| 2018-11-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919118058026/0001209191-18-058026-index.htm |
| 2018-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919118059974/0001209191-18-059974-index.htm |
| 2018-12-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919118062779/0001209191-18-062779-index.htm |
| 2018-12-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919118063581/0001209191-18-063581-index.htm |
| 2018-12-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919118063963/0001209191-18-063963-index.htm |
| 2018-12-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919118064340/0001209191-18-064340-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119001467/0001209191-19-001467-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119001472/0001209191-19-001472-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119001476/0001209191-19-001476-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119001485/0001209191-19-001485-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119001522/0001209191-19-001522-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119001537/0001209191-19-001537-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119001543/0001209191-19-001543-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119001548/0001209191-19-001548-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119001551/0001209191-19-001551-index.htm |
| 2019-01-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119003464/0001209191-19-003464-index.htm |
| 2019-01-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119004003/0001209191-19-004003-index.htm |
| 2019-01-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119004005/0001209191-19-004005-index.htm |
| 2019-01-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119004624/0001209191-19-004624-index.htm |
| 2019-01-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119004629/0001209191-19-004629-index.htm |
| 2019-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119005259/0001209191-19-005259-index.htm |
| 2019-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119005261/0001209191-19-005261-index.htm |
| 2019-02-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119006623/0001209191-19-006623-index.htm |
| 2019-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119008329/0001209191-19-008329-index.htm |
| 2019-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119009534/0001209191-19-009534-index.htm |
| 2019-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119011829/0001209191-19-011829-index.htm |
| 2019-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119011831/0001209191-19-011831-index.htm |
| 2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119013821/0001209191-19-013821-index.htm |
| 2019-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119014235/0001209191-19-014235-index.htm |
| 2019-03-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119015284/0001209191-19-015284-index.htm |
| 2019-04-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119023887/0001209191-19-023887-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119032137/0001209191-19-032137-index.htm |
| 2019-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119033290/0001209191-19-033290-index.htm |
| 2019-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119033296/0001209191-19-033296-index.htm |
| 2019-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119034038/0001209191-19-034038-index.htm |
| 2019-06-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119039549/0001209191-19-039549-index.htm |
| 2019-09-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119049237/0001209191-19-049237-index.htm |
| 2019-09-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119050606/0001209191-19-050606-index.htm |
| 2019-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119051054/0001209191-19-051054-index.htm |
| 2019-10-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119053064/0001209191-19-053064-index.htm |
| 2019-11-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119054789/0001209191-19-054789-index.htm |
| 2019-11-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119055735/0001209191-19-055735-index.htm |
| 2019-11-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119057485/0001209191-19-057485-index.htm |
| 2019-11-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119057487/0001209191-19-057487-index.htm |
| 2019-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119059171/0001209191-19-059171-index.htm |
| 2019-12-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119060507/0001209191-19-060507-index.htm |
| 2019-12-27 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119062033/0001209191-19-062033-index.htm |
| 2019-12-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919119062035/0001209191-19-062035-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120001333/0001209191-20-001333-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120001338/0001209191-20-001338-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120001343/0001209191-20-001343-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120001349/0001209191-20-001349-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120001353/0001209191-20-001353-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120001356/0001209191-20-001356-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120001359/0001209191-20-001359-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120001366/0001209191-20-001366-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120001372/0001209191-20-001372-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120002613/0001209191-20-002613-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120002615/0001209191-20-002615-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120002617/0001209191-20-002617-index.htm |
| 2020-01-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120003202/0001209191-20-003202-index.htm |
| 2020-01-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120004722/0001209191-20-004722-index.htm |
| 2020-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120010599/0001209191-20-010599-index.htm |
| 2020-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120013488/0001209191-20-013488-index.htm |
| 2020-04-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120024687/0001209191-20-024687-index.htm |
| 2020-04-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120025382/0001209191-20-025382-index.htm |
| 2020-04-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/0001209191-20-026230-index.htm |
| 2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120028975/0001209191-20-028975-index.htm |
| 2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120028978/0001209191-20-028978-index.htm |
| 2020-05-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120030214/0001209191-20-030214-index.htm |
| 2020-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120038767/0001209191-20-038767-index.htm |
| 2020-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120039148/0001209191-20-039148-index.htm |
| 2020-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120046846/0001209191-20-046846-index.htm |
| 2020-09-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120049785/0001209191-20-049785-index.htm |
| 2020-10-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120054714/0001209191-20-054714-index.htm |
| 2020-10-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120055599/0001209191-20-055599-index.htm |
| 2020-10-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120055732/0001209191-20-055732-index.htm |
| 2020-10-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120055851/0001209191-20-055851-index.htm |
| 2020-11-02 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/879407/000120919120056462/0001209191-20-056462-index.htm |
| 2018-05-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/879407/000149315218006730/0001493152-18-006730-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/879407/000149315219001946/0001493152-19-001946-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/879407/000149315220002404/0001493152-20-002404-index.htm |
| 2018-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/879407/000156459018011799/0001564590-18-011799-index.htm |
| 2018-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/879407/000156459018011813/0001564590-18-011813-index.htm |
| 2018-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/879407/000156459018019919/0001564590-18-019919-index.htm |
| 2018-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/879407/000156459018019930/0001564590-18-019930-index.htm |
| 2018-12-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/879407/000156459018030804/0001564590-18-030804-index.htm |
| 2018-12-11 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/879407/000156459018030805/0001564590-18-030805-index.htm |
| 2019-02-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/879407/000156459019002293/0001564590-19-002293-index.htm |
| 2019-04-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/879407/000156459019012117/0001564590-19-012117-index.htm |
| 2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/879407/000156459019017188/0001564590-19-017188-index.htm |
| 2019-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/879407/000156459019017199/0001564590-19-017199-index.htm |
| 2019-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/879407/000156459019028754/0001564590-19-028754-index.htm |
| 2019-08-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/879407/000156459019028760/0001564590-19-028760-index.htm |
| 2019-11-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/879407/000156459019044001/0001564590-19-044001-index.htm |
| 2019-11-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/879407/000156459019044371/0001564590-19-044371-index.htm |
| 2019-11-25 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/879407/000156459019044376/0001564590-19-044376-index.htm |
| 2020-02-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/879407/000156459020003460/0001564590-20-003460-index.htm |
| 2020-02-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/879407/000156459020003465/0001564590-20-003465-index.htm |
| 2020-03-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/879407/000156459020011831/0001564590-20-011831-index.htm |
| 2020-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/879407/000156459020020542/0001564590-20-020542-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/879407/000156459020022832/0001564590-20-022832-index.htm |
| 2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/879407/000156459020022860/0001564590-20-022860-index.htm |
| 2020-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/879407/000156459020036782/0001564590-20-036782-index.htm |
| 2020-08-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/879407/000156459020036812/0001564590-20-036812-index.htm |
| 2020-09-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/879407/000156459020042714/0001564590-20-042714-index.htm |
| 2020-10-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/879407/000156459020046215/0001564590-20-046215-index.htm |
| 2019-02-11 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/879407/000156761919002917/0001567619-19-002917-index.htm |
| 2020-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/879407/000156761920002054/0001567619-20-002054-index.htm |
| 2019-03-18 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/879407/999999999719001387/9999999997-19-001387-index.htm |
Arrowhead Pharmaceuticals, Inc (ARWR) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Arrowhead Pharmaceuticals, Inc (ARWR). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 260%Institutional Ownership: 6706%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-01-14 | BRUCE D GIVEN | Chief Operating Officer | Sell | 42,666.00 | 14.40 | 614,390.40 | 1,068,356.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119004003/0001209191-19-004003-index.htm |
| 2019-01-02 | BRUCE D GIVEN | Chief Operating Officer | Sell | 20,000.00 | 11.98 | 239,600.00 | 1,098,356.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119001472/0001209191-19-001472-index.htm |
| 2019-01-14 | BRUCE D GIVEN | Chief Operating Officer | Buy | 11,666.00 | 2.62 | 30,564.92 | 1,110,022.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119004003/0001209191-19-004003-index.htm |
| 2019-01-14 | BRUCE D GIVEN | Chief Operating Officer | Buy | 1,000.00 | 6.20 | 6,200.00 | 1,111,022.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119004003/0001209191-19-004003-index.htm |
| 2019-01-01 | BRUCE D GIVEN | Chief Operating Officer | Buy | 210,000.00 | 1,118,356.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119001472/0001209191-19-001472-index.htm | ||
| 2019-09-09 | MICHAEL S PERRY | Director | Sell | 100,000.00 | 28.90 | 2,890,000.00 | 121,000.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119049237/0001209191-19-049237-index.htm |
| 2020-01-01 | Backer Marianne De | Director | Buy | 7,500.00 | 12,500.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120001372/0001209191-20-001372-index.htm | ||
| 2020-01-13 | Backer Marianne De | Director | Buy | 500.00 | 54.95 | 27,475.00 | 13,000.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120038767/0001209191-20-038767-index.htm |
| 2018-10-19 | Peter Brian Leone | VP, Strategic Bus. Initiatives | Sell | 131,137.00 | 13.49 | 1,769,038.13 | 130,000.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919118055999/0001209191-18-055999-index.htm |
| 2020-02-27 | Backer Marianne De | Director | Buy | 500.00 | 35.07 | 17,535.00 | 13,500.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120038767/0001209191-20-038767-index.htm |
| 2020-02-28 | Backer Marianne De | Director | Buy | 500.00 | 34.39 | 17,195.00 | 14,000.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120038767/0001209191-20-038767-index.htm |
| 2020-05-12 | MICHAEL S PERRY | Director | Sell | 29,900.00 | 35.71 | 1,067,729.00 | 14,100.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120028978/0001209191-20-028978-index.htm |
| 2020-01-01 | Mauro Ferrari | Director | Buy | 7,500.00 | 14,400.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120001338/0001209191-20-001338-index.htm | ||
| 2020-03-11 | Backer Marianne De | Director | Buy | 500.00 | 28.60 | 14,300.00 | 14,500.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120038767/0001209191-20-038767-index.htm |
| 2018-12-27 | DOUGLAS B GIVEN | Director | Sell | 3,000.00 | 12.00 | 36,000.00 | 145,130.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919118064340/0001209191-18-064340-index.htm |
| 2018-11-23 | DOUGLAS B GIVEN | Director | Sell | 3,000.00 | 12.74 | 38,220.00 | 148,130.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919118059974/0001209191-18-059974-index.htm |
| 2020-03-12 | Backer Marianne De | Director | Buy | 500.00 | 24.80 | 12,400.00 | 15,000.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120038767/0001209191-20-038767-index.htm |
| 2020-05-14 | MICHAEL S PERRY | Director | Buy | 7,000.00 | 4.75 | 33,250.00 | 15,000.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120030214/0001209191-20-030214-index.htm |
| 2018-12-19 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 90,000.00 | 13.92 | 1,252,800.00 | 1,542,455.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919118063963/0001209191-18-063963-index.htm |
| 2020-03-16 | Backer Marianne De | Director | Buy | 500.00 | 23.94 | 11,970.00 | 15,500.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120038767/0001209191-20-038767-index.htm |
| 2018-04-24 | DOUGLAS B GIVEN | Director | Sell | 25,000.00 | 6.63 | 165,750.00 | 155,000.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919118026146/0001209191-18-026146-index.htm |
| 2020-04-14 | DOUGLAS B GIVEN | Director | Sell | 25,000.00 | 36.89 | 922,250.00 | 155,925.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120024687/0001209191-20-024687-index.htm |
| 2020-04-15 | Backer Marianne De | Director | Buy | 500.00 | 35.40 | 17,700.00 | 16,000.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120038767/0001209191-20-038767-index.htm |
| 2018-10-19 | Peter Brian Leone | VP, Strategic Bus. Initiatives | Buy | 30,000.00 | 2.79 | 83,700.00 | 160,000.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919118055999/0001209191-18-055999-index.htm |
| 2018-12-18 | Mauro Ferrari | Director | Buy | 3,459.00 | 16,227.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919118063581/0001209191-18-063581-index.htm | ||
| 2018-12-12 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 90,000.00 | 14.07 | 1,266,300.00 | 1,632,455.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919118062779/0001209191-18-062779-index.htm |
| 2020-06-15 | Backer Marianne De | Director | Buy | 500.00 | 31.33 | 15,665.00 | 16,500.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120038767/0001209191-20-038767-index.htm |
| 2018-11-09 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 5,300.00 | 14.95 | 79,235.00 | 1,722,455.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919118058026/0001209191-18-058026-index.htm |
| 2018-11-09 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 76,200.00 | 14.35 | 1,093,470.00 | 1,727,755.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919118058026/0001209191-18-058026-index.htm |
| 2019-02-22 | DOUGLAS B GIVEN | Director | Sell | 3,000.00 | 18.05 | 54,150.00 | 175,130.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119013821/0001209191-19-013821-index.htm |
| 2019-02-26 | DOUGLAS B GIVEN | Director | Sell | 65,000.00 | 19.25 | 1,251,250.00 | 175,130.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119013821/0001209191-19-013821-index.htm |
| 2019-01-22 | DOUGLAS B GIVEN | Director | Sell | 3,000.00 | 13.58 | 40,740.00 | 178,130.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119005259/0001209191-19-005259-index.htm |
| 2018-09-04 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 64,834.00 | 14.45 | 936,851.30 | 1,803,955.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919118049552/0001209191-18-049552-index.htm |
| 2019-12-24 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 83,333.00 | 63.50 | 5,291,645.50 | 1,805,237.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119062035/0001209191-19-062035-index.htm |
| 2020-01-01 | DOUGLAS B GIVEN | Director | Buy | 8,000.00 | 180,925.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120001333/0001209191-20-001333-index.htm | ||
| 2019-01-01 | DOUGLAS B GIVEN | Director | Buy | 36,000.00 | 181,130.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119001537/0001209191-19-001537-index.htm | ||
| 2018-08-31 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 100,000.00 | 14.45 | 1,445,000.00 | 1,868,789.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919118049552/0001209191-18-049552-index.htm |
| 2019-12-13 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 3,393.00 | 68.18 | 231,334.74 | 1,888,570.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119060507/0001209191-19-060507-index.htm |
| 2019-12-13 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 25,412.00 | 67.30 | 1,710,227.60 | 1,891,963.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119060507/0001209191-19-060507-index.htm |
| 2019-06-26 | Mauro Ferrari | Director | Sell | 17,756.00 | 27.61 | 490,243.16 | 1,900.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119039549/0001209191-19-039549-index.htm |
| 2019-12-13 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 45,577.00 | 66.47 | 3,029,503.19 | 1,917,375.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119060507/0001209191-19-060507-index.htm |
| 2018-10-19 | Peter Brian Leone | VP, Strategic Bus. Initiatives | Buy | 34,375.00 | 6.15 | 211,406.25 | 194,375.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919118055999/0001209191-18-055999-index.htm |
| 2019-12-13 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 8,951.00 | 65.85 | 589,423.35 | 1,962,952.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119060507/0001209191-19-060507-index.htm |
| 2019-01-02 | Mauro Ferrari | Director | Buy | 3,429.00 | 19,656.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119001548/0001209191-19-001548-index.htm | ||
| 2019-12-12 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 8,379.00 | 69.41 | 581,586.39 | 1,971,903.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119060507/0001209191-19-060507-index.htm |
| 2019-12-12 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 10,343.00 | 68.51 | 708,598.93 | 1,980,282.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119060507/0001209191-19-060507-index.htm |
| 2019-12-12 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 58,059.00 | 67.31 | 3,907,951.29 | 1,990,625.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119060507/0001209191-19-060507-index.htm |
| 2020-05-14 | MICHAEL S PERRY | Director | Buy | 5,000.00 | 2.01 | 10,050.00 | 20,000.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120030214/0001209191-20-030214-index.htm |
| 2019-01-14 | Zhen Li | Snr. VP, Chem and Non-Clin Dev | Sell | 40,500.00 | 14.34 | 580,770.00 | 201,700.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119004005/0001209191-19-004005-index.htm |
| 2019-05-28 | Patrick O'Brien | General Counsel | Sell | 30,000.00 | 24.88 | 746,400.00 | 203,000.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119033296/0001209191-19-033296-index.htm |
| 2019-12-12 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 23,219.00 | 66.82 | 1,551,493.58 | 2,048,684.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119060507/0001209191-19-060507-index.htm |
| 2019-02-26 | DOUGLAS B GIVEN | Director | Buy | 30,000.00 | 5.19 | 155,700.00 | 205,130.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119013821/0001209191-19-013821-index.htm |
| 2019-12-03 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 8,022.00 | 62.00 | 497,364.00 | 2,071,903.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119059171/0001209191-19-059171-index.htm |
| 2019-12-03 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 4,011.00 | 60.73 | 243,588.03 | 2,079,925.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119059171/0001209191-19-059171-index.htm |
| 2019-12-02 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 3,656.00 | 72.95 | 266,705.20 | 2,083,936.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119059171/0001209191-19-059171-index.htm |
| 2019-12-02 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 3,800.00 | 72.13 | 274,094.00 | 2,087,592.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119059171/0001209191-19-059171-index.htm |
| 2019-12-02 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 2,448.00 | 70.72 | 173,122.56 | 2,091,392.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119059171/0001209191-19-059171-index.htm |
| 2019-04-03 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 50,000.00 | 19.30 | 965,000.00 | 2,092,455.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119023887/0001209191-19-023887-index.htm |
| 2019-12-02 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 6,617.00 | 69.50 | 459,881.50 | 2,093,840.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119059171/0001209191-19-059171-index.htm |
| 2019-12-02 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 8,510.00 | 68.50 | 582,935.00 | 2,100,457.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119059171/0001209191-19-059171-index.htm |
| 2019-12-02 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 7,193.00 | 67.63 | 486,462.59 | 2,108,967.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119059171/0001209191-19-059171-index.htm |
| 2019-12-02 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 5,743.00 | 66.58 | 382,368.94 | 2,116,160.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119059171/0001209191-19-059171-index.htm |
| 2019-09-25 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 20,000.00 | 28.25 | 565,000.00 | 2,121,903.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119051054/0001209191-19-051054-index.htm |
| 2019-10-10 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 56,325.00 | 31.83 | 1,792,824.75 | 2,121,903.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119053064/0001209191-19-053064-index.htm |
| 2019-05-24 | Christopher Richard Anzalone | Chief Executive Officer | Buy | 40,072.00 | 2.01 | 80,544.72 | 2,132,527.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119033290/0001209191-19-033290-index.htm |
| 2019-05-24 | Christopher Richard Anzalone | Chief Executive Officer | Buy | 9,376.00 | 2.62 | 24,565.12 | 2,141,903.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119033290/0001209191-19-033290-index.htm |
| 2019-09-20 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 4,250.00 | 29.00 | 123,250.00 | 2,141,903.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119050606/0001209191-19-050606-index.htm |
| 2019-09-23 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 41,755.00 | 29.04 | 1,212,565.20 | 2,141,903.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119050606/0001209191-19-050606-index.htm |
| 2019-09-24 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 12,673.00 | 29.04 | 368,023.92 | 2,141,903.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119050606/0001209191-19-050606-index.htm |
| 2019-01-01 | Christopher Richard Anzalone | Chief Executive Officer | Buy | 600,000.00 | 2,142,455.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119001467/0001209191-19-001467-index.htm | ||
| 2019-09-20 | Christopher Richard Anzalone | Chief Executive Officer | Buy | 4,250.00 | 5.10 | 21,675.00 | 2,146,153.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119050606/0001209191-19-050606-index.htm |
| 2019-09-24 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 53,972.00 | 28.00 | 1,511,216.00 | 2,154,576.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119050606/0001209191-19-050606-index.htm |
| 2019-10-10 | Christopher Richard Anzalone | Chief Executive Officer | Buy | 56,325.00 | 5.20 | 292,890.00 | 2,178,228.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119053064/0001209191-19-053064-index.htm |
| 2019-09-23 | Christopher Richard Anzalone | Chief Executive Officer | Buy | 41,755.00 | 5.10 | 212,950.50 | 2,183,658.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119050606/0001209191-19-050606-index.htm |
| 2019-09-24 | Christopher Richard Anzalone | Chief Executive Officer | Buy | 66,645.00 | 5.10 | 339,889.50 | 2,208,548.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119050606/0001209191-19-050606-index.htm |
| 2019-01-01 | MICHAEL S PERRY | Director | Buy | 36,000.00 | 221,000.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119001543/0001209191-19-001543-index.htm | ||
| 2019-02-26 | DOUGLAS B GIVEN | Director | Buy | 18,000.00 | 2.19 | 39,420.00 | 223,130.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119013821/0001209191-19-013821-index.htm |
| 2019-01-18 | Patrick O'Brien | General Counsel | Sell | 72,000.00 | 14.43 | 1,038,960.00 | 233,000.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119004629/0001209191-19-004629-index.htm |
| 2019-02-26 | DOUGLAS B GIVEN | Director | Buy | 10,000.00 | 2.62 | 26,200.00 | 233,130.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119013821/0001209191-19-013821-index.htm |
| 2019-02-26 | DOUGLAS B GIVEN | Director | Buy | 7,000.00 | 4.75 | 33,250.00 | 240,130.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119013821/0001209191-19-013821-index.htm |
| 2019-01-01 | Zhen Li | Snr. VP, Chem and Non-Clin Dev | Buy | 75,000.00 | 242,200.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119001522/0001209191-19-001522-index.htm | ||
| 2020-10-23 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 12,272.00 | 58.57 | 718,771.04 | 2,505,237.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120055732/0001209191-20-055732-index.htm |
| 2020-10-23 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 87,728.00 | 58.16 | 5,102,260.48 | 2,517,509.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120055732/0001209191-20-055732-index.htm |
| 2020-01-06 | Patrick O'Brien | General Counsel | Sell | 100.00 | 61.02 | 6,102.00 | 258,375.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120002615/0001209191-20-002615-index.htm |
| 2020-01-06 | Patrick O'Brien | General Counsel | Sell | 8,931.00 | 60.43 | 539,700.33 | 258,475.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120002615/0001209191-20-002615-index.htm |
| 2020-06-25 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 23.00 | 39.55 | 909.65 | 2,605,237.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120039148/0001209191-20-039148-index.htm |
| 2020-08-13 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 50,000.00 | 41.35 | 2,067,500.00 | 2,605,237.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120046846/0001209191-20-046846-index.htm |
| 2020-06-25 | Christopher Richard Anzalone | Chief Executive Officer | Sell | 99,977.00 | 38.81 | 3,880,107.37 | 2,605,260.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120039148/0001209191-20-039148-index.htm |
| 2018-10-19 | Peter Brian Leone | VP, Strategic Bus. Initiatives | Buy | 66,762.00 | 7.75 | 517,405.50 | 261,137.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919118055999/0001209191-18-055999-index.htm |
| 2020-08-13 | Christopher Richard Anzalone | Chief Executive Officer | Buy | 50,000.00 | 9.90 | 495,000.00 | 2,655,237.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120046846/0001209191-20-046846-index.htm |
| 2020-01-06 | Patrick O'Brien | General Counsel | Sell | 5,594.00 | 59.61 | 333,458.34 | 267,406.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120002615/0001209191-20-002615-index.htm |
| 2020-01-01 | Christopher Richard Anzalone | Chief Executive Officer | Buy | 900,000.00 | 2,705,237.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120001349/0001209191-20-001349-index.htm | ||
| 2020-01-01 | Patrick O'Brien | General Counsel | Buy | 70,000.00 | 273,000.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120001353/0001209191-20-001353-index.htm | ||
| 2019-05-21 | Kenneth Allen Myszkowski | Chief Financial Officer | Sell | 27,071.00 | 22.00 | 595,562.00 | 278,536.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119032137/0001209191-19-032137-index.htm |
| 2020-05-11 | William D. Waddill | Director | Sell | 26,000.00 | 36.54 | 950,040.00 | 28,000.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120028975/0001209191-20-028975-index.htm |
| 2019-05-31 | Kenneth Allen Myszkowski | Chief Financial Officer | Buy | 15,000.00 | 4.60 | 69,000.00 | 293,536.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119034038/0001209191-19-034038-index.htm |
| 2019-01-01 | Patrick O'Brien | General Counsel | Buy | 70,000.00 | 305,000.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119001485/0001209191-19-001485-index.htm | ||
| 2019-01-17 | Kenneth Allen Myszkowski | Chief Financial Officer | Sell | 81,875.00 | 14.55 | 1,191,281.25 | 305,607.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119004624/0001209191-19-004624-index.htm |
| 2019-02-19 | Kenneth Allen Myszkowski | Chief Financial Officer | Sell | 8,000.00 | 18.00 | 144,000.00 | 305,607.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119011831/0001209191-19-011831-index.htm |
| 2020-10-09 | Mauro Ferrari | Director | Sell | 10,000.00 | 48.00 | 480,000.00 | 30,971.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120054714/0001209191-20-054714-index.htm |
| 2018-03-27 | Kenneth Allen Myszkowski | Chief Financial Officer | Sell | 20,000.00 | 8.00 | 160,000.00 | 310,815.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919118021843/0001209191-18-021843-index.htm |
| 2018-05-30 | Kenneth Allen Myszkowski | Chief Financial Officer | Sell | 1,400.00 | 11.00 | 15,400.00 | 310,815.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919118034785/0001209191-18-034785-index.htm |
| 2018-05-31 | Kenneth Allen Myszkowski | Chief Financial Officer | Sell | 12,600.00 | 11.00 | 138,600.00 | 310,815.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919118034785/0001209191-18-034785-index.htm |
| 2018-06-19 | Kenneth Allen Myszkowski | Chief Financial Officer | Sell | 20,000.00 | 14.01 | 280,200.00 | 310,815.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919118038884/0001209191-18-038884-index.htm |
| 2018-09-06 | Kenneth Allen Myszkowski | Chief Financial Officer | Sell | 20,000.00 | 21.01 | 420,200.00 | 310,815.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919118050356/0001209191-18-050356-index.htm |
| 2018-05-30 | Kenneth Allen Myszkowski | Chief Financial Officer | Buy | 1,400.00 | 2.01 | 2,814.00 | 312,215.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919118034785/0001209191-18-034785-index.htm |
| 2019-05-31 | Kenneth Allen Myszkowski | Chief Financial Officer | Buy | 20,000.00 | 5.19 | 103,800.00 | 313,536.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119034038/0001209191-19-034038-index.htm |
| 2019-11-01 | Kenneth Allen Myszkowski | Chief Financial Officer | Sell | 16,620.00 | 41.21 | 684,910.20 | 313,536.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119054789/0001209191-19-054789-index.htm |
| 2019-02-19 | Kenneth Allen Myszkowski | Chief Financial Officer | Buy | 8,000.00 | 5.20 | 41,600.00 | 313,607.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119011831/0001209191-19-011831-index.htm |
| 2018-05-31 | Kenneth Allen Myszkowski | Chief Financial Officer | Buy | 12,600.00 | 2.01 | 25,326.00 | 323,415.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919118034785/0001209191-18-034785-index.htm |
| 2019-11-05 | Kenneth Allen Myszkowski | Chief Financial Officer | Buy | 12,649.00 | 5.19 | 65,648.31 | 326,185.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119055735/0001209191-19-055735-index.htm |
| 2019-11-01 | Kenneth Allen Myszkowski | Chief Financial Officer | Sell | 21,264.00 | 40.56 | 862,467.84 | 330,156.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119054789/0001209191-19-054789-index.htm |
| 2018-03-27 | Kenneth Allen Myszkowski | Chief Financial Officer | Buy | 20,000.00 | 2.01 | 40,200.00 | 330,815.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919118021843/0001209191-18-021843-index.htm |
| 2018-06-19 | Kenneth Allen Myszkowski | Chief Financial Officer | Buy | 20,000.00 | 2.01 | 40,200.00 | 330,815.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919118038884/0001209191-18-038884-index.htm |
| 2018-09-06 | Kenneth Allen Myszkowski | Chief Financial Officer | Sell | 25,000.00 | 18.00 | 450,000.00 | 330,815.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919118050356/0001209191-18-050356-index.htm |
| 2018-09-06 | Kenneth Allen Myszkowski | Chief Financial Officer | Buy | 25,000.00 | 2.62 | 65,500.00 | 335,815.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919118050356/0001209191-18-050356-index.htm |
| 2020-05-14 | MICHAEL S PERRY | Director | Buy | 15,000.00 | 2.19 | 32,850.00 | 35,000.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120030214/0001209191-20-030214-index.htm |
| 2019-11-01 | Kenneth Allen Myszkowski | Chief Financial Officer | Buy | 37,884.00 | 7.75 | 293,601.00 | 351,420.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119054789/0001209191-19-054789-index.htm |
| 2018-09-06 | Kenneth Allen Myszkowski | Chief Financial Officer | Buy | 20,000.00 | 4.75 | 95,000.00 | 355,815.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919118050356/0001209191-18-050356-index.htm |
| 2019-09-11 | MICHAEL S PERRY | Director | Sell | 85,000.00 | 30.00 | 2,550,000.00 | 36,000.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119049237/0001209191-19-049237-index.htm |
| 2020-01-21 | Kenneth Allen Myszkowski | Chief Financial Officer | Sell | 3,450.00 | 52.13 | 179,848.50 | 384,223.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120004722/0001209191-20-004722-index.htm |
| 2019-01-02 | Kenneth Allen Myszkowski | Chief Financial Officer | Sell | 8,333.00 | 11.98 | 99,829.34 | 387,482.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119001476/0001209191-19-001476-index.htm |
| 2020-01-21 | Kenneth Allen Myszkowski | Chief Financial Officer | Sell | 10,680.00 | 51.11 | 545,854.80 | 387,673.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120004722/0001209191-20-004722-index.htm |
| 2020-01-06 | Kenneth Allen Myszkowski | Chief Financial Officer | Sell | 500.00 | 60.95 | 30,475.00 | 391,185.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120002613/0001209191-20-002613-index.htm |
| 2020-01-06 | Kenneth Allen Myszkowski | Chief Financial Officer | Sell | 11,907.00 | 60.40 | 719,182.80 | 391,685.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120002613/0001209191-20-002613-index.htm |
| 2019-01-01 | Kenneth Allen Myszkowski | Chief Financial Officer | Buy | 85,000.00 | 395,815.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119001476/0001209191-19-001476-index.htm | ||
| 2020-02-25 | Kenneth Allen Myszkowski | Chief Financial Officer | Buy | 12,000.00 | 9.90 | 118,800.00 | 396,223.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120013488/0001209191-20-013488-index.htm |
| 2020-02-25 | Kenneth Allen Myszkowski | Chief Financial Officer | Buy | 2,000.00 | 5.19 | 10,380.00 | 398,223.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120013488/0001209191-20-013488-index.htm |
| 2020-01-21 | Kenneth Allen Myszkowski | Chief Financial Officer | Sell | 2,800.00 | 49.98 | 139,944.00 | 398,353.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120004722/0001209191-20-004722-index.htm |
| 2020-01-21 | Kenneth Allen Myszkowski | Chief Financial Officer | Sell | 10,554.00 | 49.07 | 517,884.78 | 401,153.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120004722/0001209191-20-004722-index.htm |
| 2020-01-06 | Kenneth Allen Myszkowski | Chief Financial Officer | Sell | 7,593.00 | 59.60 | 452,542.80 | 403,592.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120002613/0001209191-20-002613-index.htm |
| 2020-02-25 | Kenneth Allen Myszkowski | Chief Financial Officer | Buy | 6,495.00 | 14.54 | 94,437.30 | 404,718.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120013488/0001209191-20-013488-index.htm |
| 2020-02-17 | Mauro Ferrari | Director | Buy | 26,571.00 | 40,971.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120010599/0001209191-20-010599-index.htm | ||
| 2020-01-01 | Kenneth Allen Myszkowski | Chief Financial Officer | Buy | 85,000.00 | 411,185.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120001343/0001209191-20-001343-index.htm | ||
| 2020-01-21 | Kenneth Allen Myszkowski | Chief Financial Officer | Sell | 6,432.00 | 47.93 | 308,285.76 | 411,707.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120004722/0001209191-20-004722-index.htm |
| 2020-02-25 | Kenneth Allen Myszkowski | Chief Financial Officer | Buy | 12,116.00 | 7.75 | 93,899.00 | 416,834.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120013488/0001209191-20-013488-index.htm |
| 2020-01-21 | Kenneth Allen Myszkowski | Chief Financial Officer | Sell | 6,397.00 | 47.07 | 301,106.79 | 418,139.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120004722/0001209191-20-004722-index.htm |
| 2020-01-21 | Kenneth Allen Myszkowski | Chief Financial Officer | Buy | 33,351.00 | 5.19 | 173,091.69 | 424,536.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120004722/0001209191-20-004722-index.htm |
| 2020-02-25 | Kenneth Allen Myszkowski | Chief Financial Officer | Buy | 10,834.00 | 6.15 | 66,629.10 | 427,668.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120013488/0001209191-20-013488-index.htm |
| 2020-10-20 | Kenneth Allen Myszkowski | Chief Financial Officer | Sell | 29,166.00 | 54.04 | 1,576,130.64 | 427,668.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120055599/0001209191-20-055599-index.htm |
| 2020-01-01 | MICHAEL S PERRY | Director | Buy | 8,000.00 | 44,000.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120001366/0001209191-20-001366-index.htm | ||
| 2020-05-14 | MICHAEL S PERRY | Director | Buy | 10,000.00 | 2.62 | 26,200.00 | 45,000.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120030214/0001209191-20-030214-index.htm |
| 2020-10-20 | Kenneth Allen Myszkowski | Chief Financial Officer | Buy | 29,166.00 | 6.15 | 179,370.90 | 456,834.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120055599/0001209191-20-055599-index.htm |
| 2019-01-11 | William D. Waddill | Director | Sell | 8,500.00 | 14.77 | 125,545.00 | 46,500.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119003464/0001209191-19-003464-index.htm |
| 2020-01-01 | William D. Waddill | Director | Buy | 7,500.00 | 54,000.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120001359/0001209191-20-001359-index.htm | ||
| 2019-01-01 | William D. Waddill | Director | Buy | 30,000.00 | 55,000.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119001551/0001209191-19-001551-index.htm | ||
| 2020-05-14 | MICHAEL S PERRY | Director | Buy | 15,000.00 | 5.19 | 77,850.00 | 60,000.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120030214/0001209191-20-030214-index.htm |
| 2019-02-15 | BRUCE D GIVEN | Chief Operating Officer | Sell | 26,250.00 | 17.67 | 463,837.50 | 644,606.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119011829/0001209191-19-011829-index.htm |
| 2019-02-19 | BRUCE D GIVEN | Chief Operating Officer | Sell | 42,500.00 | 17.98 | 764,150.00 | 644,606.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119011829/0001209191-19-011829-index.htm |
| 2019-02-25 | BRUCE D GIVEN | Chief Operating Officer | Sell | 42,500.00 | 18.98 | 806,650.00 | 644,606.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119014235/0001209191-19-014235-index.htm |
| 2019-03-01 | BRUCE D GIVEN | Chief Operating Officer | Sell | 42,500.00 | 19.99 | 849,575.00 | 644,606.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119015284/0001209191-19-015284-index.htm |
| 2019-02-11 | BRUCE D GIVEN | Chief Operating Officer | Sell | 57,000.00 | 16.48 | 939,360.00 | 670,856.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119009534/0001209191-19-009534-index.htm |
| 2019-02-12 | BRUCE D GIVEN | Chief Operating Officer | Sell | 42,500.00 | 17.06 | 725,050.00 | 670,856.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119009534/0001209191-19-009534-index.htm |
| 2019-02-19 | BRUCE D GIVEN | Chief Operating Officer | Buy | 42,500.00 | 2.01 | 85,425.00 | 687,106.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119011829/0001209191-19-011829-index.htm |
| 2019-02-25 | BRUCE D GIVEN | Chief Operating Officer | Buy | 42,500.00 | 2.01 | 85,425.00 | 687,106.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119014235/0001209191-19-014235-index.htm |
| 2019-03-01 | BRUCE D GIVEN | Chief Operating Officer | Buy | 42,500.00 | 2.01 | 85,425.00 | 687,106.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119015284/0001209191-19-015284-index.htm |
| 2019-02-12 | BRUCE D GIVEN | Chief Operating Officer | Buy | 42,500.00 | 2.01 | 85,425.00 | 713,356.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119009534/0001209191-19-009534-index.htm |
| 2019-02-11 | BRUCE D GIVEN | Chief Operating Officer | Sell | 97,167.00 | 15.66 | 1,521,635.22 | 727,856.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119009534/0001209191-19-009534-index.htm |
| 2020-05-12 | MICHAEL S PERRY | Director | Sell | 6,100.00 | 36.42 | 222,162.00 | 8,000.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120028978/0001209191-20-028978-index.htm |
| 2019-02-08 | BRUCE D GIVEN | Chief Operating Officer | Sell | 46,167.00 | 15.34 | 708,201.78 | 813,356.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119009534/0001209191-19-009534-index.htm |
| 2019-02-11 | BRUCE D GIVEN | Chief Operating Officer | Buy | 11,667.00 | 2.62 | 30,567.54 | 825,023.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119009534/0001209191-19-009534-index.htm |
| 2019-02-05 | BRUCE D GIVEN | Chief Operating Officer | Sell | 22,500.00 | 14.48 | 325,800.00 | 847,856.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119008329/0001209191-19-008329-index.htm |
| 2020-05-14 | MICHAEL S PERRY | Director | Buy | 25,000.00 | 4.20 | 105,000.00 | 85,000.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120030214/0001209191-20-030214-index.htm |
| 2020-04-28 | BRUCE D GIVEN | Chief Operating Officer | Sell | 700.00 | 40.00 | 28,000.00 | 850,730.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/0001209191-20-026230-index.htm |
| 2020-04-28 | BRUCE D GIVEN | Chief Operating Officer | Sell | 204.00 | 40.00 | 8,160.00 | 851,430.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/0001209191-20-026230-index.htm |
| 2020-04-27 | BRUCE D GIVEN | Chief Operating Officer | Sell | 100.00 | 40.00 | 4,000.00 | 851,634.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/0001209191-20-026230-index.htm |
| 2020-04-28 | BRUCE D GIVEN | Chief Operating Officer | Sell | 213.00 | 40.00 | 8,520.00 | 851,634.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/0001209191-20-026230-index.htm |
| 2020-04-20 | BRUCE D GIVEN | Chief Operating Officer | Sell | 3,805.00 | 40.00 | 152,200.00 | 851,734.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120025382/0001209191-20-025382-index.htm |
| 2020-04-27 | BRUCE D GIVEN | Chief Operating Officer | Sell | 200.00 | 40.00 | 8,000.00 | 851,734.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/0001209191-20-026230-index.htm |
| 2020-04-28 | BRUCE D GIVEN | Chief Operating Officer | Sell | 830.00 | 40.00 | 33,200.00 | 851,847.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/0001209191-20-026230-index.htm |
| 2020-04-27 | BRUCE D GIVEN | Chief Operating Officer | Buy | 200.00 | 5.19 | 1,038.00 | 851,934.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/0001209191-20-026230-index.htm |
| 2020-04-28 | BRUCE D GIVEN | Chief Operating Officer | Buy | 500.00 | 7.75 | 3,875.00 | 852,134.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/0001209191-20-026230-index.htm |
| 2020-04-28 | BRUCE D GIVEN | Chief Operating Officer | Sell | 1,200.00 | 40.00 | 48,000.00 | 852,677.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/0001209191-20-026230-index.htm |
| 2020-04-28 | BRUCE D GIVEN | Chief Operating Officer | Buy | 1,454.00 | 14.54 | 21,141.16 | 853,588.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/0001209191-20-026230-index.htm |
| 2020-04-28 | BRUCE D GIVEN | Chief Operating Officer | Sell | 1,454.00 | 40.00 | 58,160.00 | 853,877.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/0001209191-20-026230-index.htm |
| 2020-04-28 | BRUCE D GIVEN | Chief Operating Officer | Buy | 1,200.00 | 4.75 | 5,700.00 | 854,788.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/0001209191-20-026230-index.htm |
| 2020-04-28 | BRUCE D GIVEN | Chief Operating Officer | Sell | 500.00 | 40.00 | 20,000.00 | 855,331.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/0001209191-20-026230-index.htm |
| 2020-04-20 | BRUCE D GIVEN | Chief Operating Officer | Sell | 3,454.00 | 40.00 | 138,160.00 | 855,539.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120025382/0001209191-20-025382-index.htm |
| 2020-04-28 | BRUCE D GIVEN | Chief Operating Officer | Buy | 830.00 | 5.19 | 4,307.70 | 855,618.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/0001209191-20-026230-index.htm |
| 2020-04-28 | BRUCE D GIVEN | Chief Operating Officer | Buy | 213.00 | 5.20 | 1,107.60 | 855,831.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/0001209191-20-026230-index.htm |
| 2020-01-06 | BRUCE D GIVEN | Chief Operating Officer | Sell | 1,300.00 | 60.99 | 79,287.00 | 858,993.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120002617/0001209191-20-002617-index.htm |
| 2020-04-20 | BRUCE D GIVEN | Chief Operating Officer | Sell | 5,300.00 | 40.00 | 212,000.00 | 858,993.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120025382/0001209191-20-025382-index.htm |
| 2019-02-08 | BRUCE D GIVEN | Chief Operating Officer | Buy | 11,667.00 | 2.62 | 30,567.54 | 859,523.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119009534/0001209191-19-009534-index.htm |
| 2020-01-06 | BRUCE D GIVEN | Chief Operating Officer | Sell | 22,466.00 | 60.37 | 1,356,272.42 | 860,293.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120002617/0001209191-20-002617-index.htm |
| 2020-04-20 | BRUCE D GIVEN | Chief Operating Officer | Buy | 3,800.00 | 4.75 | 18,050.00 | 862,793.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120025382/0001209191-20-025382-index.htm |
| 2020-04-20 | BRUCE D GIVEN | Chief Operating Officer | Sell | 3,456.00 | 40.00 | 138,240.00 | 864,293.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120025382/0001209191-20-025382-index.htm |
| 2020-04-20 | BRUCE D GIVEN | Chief Operating Officer | Buy | 3,700.00 | 5.19 | 19,203.00 | 866,493.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120025382/0001209191-20-025382-index.htm |
| 2020-04-20 | BRUCE D GIVEN | Chief Operating Officer | Sell | 3,700.00 | 40.00 | 148,000.00 | 867,749.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120025382/0001209191-20-025382-index.htm |
| 2020-04-20 | BRUCE D GIVEN | Chief Operating Officer | Buy | 3,456.00 | 5.20 | 17,971.20 | 869,949.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120025382/0001209191-20-025382-index.htm |
| 2019-02-01 | BRUCE D GIVEN | Chief Operating Officer | Sell | 28,500.00 | 13.85 | 394,725.00 | 870,356.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119006623/0001209191-19-006623-index.htm |
| 2020-04-20 | BRUCE D GIVEN | Chief Operating Officer | Sell | 3,800.00 | 40.00 | 152,000.00 | 871,449.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120025382/0001209191-20-025382-index.htm |
| 2020-04-20 | BRUCE D GIVEN | Chief Operating Officer | Buy | 5,300.00 | 14.54 | 77,062.00 | 875,249.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120025382/0001209191-20-025382-index.htm |
| 2020-01-06 | BRUCE D GIVEN | Chief Operating Officer | Sell | 11,847.00 | 59.57 | 705,725.79 | 882,759.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120002617/0001209191-20-002617-index.htm |
| 2020-01-01 | BRUCE D GIVEN | Chief Operating Officer | Buy | 250,000.00 | 894,606.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919120001356/0001209191-20-001356-index.htm | ||
| 2019-01-23 | BRUCE D GIVEN | Chief Operating Officer | Sell | 17,500.00 | 13.15 | 230,125.00 | 898,856.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119005261/0001209191-19-005261-index.htm |
| 2019-01-22 | BRUCE D GIVEN | Chief Operating Officer | Sell | 152,000.00 | 13.59 | 2,065,680.00 | 916,356.00 | https://www.sec.gov/Archives/edgar/data/879407/000120919119005261/0001209191-19-005261-index.htm |